FlowReserve Labs
FlowReserve is a company specializing in personalized medicine in cardiology. Their core technology focuses on preventing cardiovascular diseases by analyzing biological fluids and medical imaging using artificial intelligence and computational fluid dynamics (CFD). Their flagship product, FFRct, provides a non-invasive cardiovascular diagnostic report by calculating the FFR indicator from a patient's CT angiography study. This offers a cheaper, less invasive, and equally accurate method compared to conventional FFR, leading to improved patient quality of life, cost savings for healthcare systems, and faster, more precise diagnoses. They aim for FFRct to become the gold standard in cardiovascular diagnostics within five years.
FlowReserve Labs
FlowReserve is a company specializing in personalized medicine in cardiology. Their core technology focuses on preventing cardiovascular diseases by analyzing biological fluids and medical imaging using artificial intelligence and computational fluid dynamics (CFD). Their flagship product, FFRct, provides a non-invasive cardiovascular diagnostic report by calculating the FFR indicator from a patient's CT angiography study. This offers a cheaper, less invasive, and equally accurate method compared to conventional FFR, leading to improved patient quality of life, cost savings for healthcare systems, and faster, more precise diagnoses. They aim for FFRct to become the gold standard in cardiovascular diagnostics within five years.